Redmile Group, LLC - Dec 20, 2024 Form SCHEDULE 13D/A Schedule Report for FATE THERAPEUTICS INC (FATE)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
FATE THERAPEUTICS INC Common Stock, $0.001 par value per share
Symbol
FATE
Shares outstanding
120M shares
Disclosed Ownership
17.8M shares
Ownership
14.9%
Form type
SCHEDULE 13D/A
Date filed
12/26/2024, 09:00 PM
Date of event
Dec 20, 2024
SEC
View on sec.gov

Reporting Managers (3)